Thailand has granted emergency authorization to Janssen, the single-dose coronavirus vaccine of Johnson & Johnson, the country's health minister said on Thursday, the third vaccine to be cleared for local use.
Anutin Charnvirankul told before media that the Food and Drug Administration (FDA) had approved the vaccine, in addition to those of AstraZeneca and Sinovac Biotech, which have already been administered in the country.
China's Sinopharm and the makers of Russia's Sputnik V and are preparing to submit requests for approval, Paisal Dunkhum head of Thailand's FDA said. Moderna has said it would submit an application for approval while India's Bharat Biotech is in the process submitting documents for vaccine registration, Paisal said.
Thailand, which has recorded just over 28,000 coronavirus cases overall, has administered about 100,000 doses of vaccines among medical workers and high-risk groups so far. It's main vaccine drive is expected to start in June, using locally-produced AstraZeneca shots and it plans to inoculate half of its adult population by the end of the year.
Meantime, Hoteliers are keen to deploy vaccines faster and wider to speed up the revival. "The government has to expedite approval of additional vaccine brands and import more vaccines and inoculate more people immediately," Thai Hotels Association president Marisa Sukosol Nunbhakdi said.
No quarantine mandatory for international travellers in Mumbai if vaccinated
Australia's Victoria to resume receiving international arrivals from April 8
Covid19: Sri Lanka to reopen all schools from March 29